Telix Completes Acquisition of European Radiopharmaceutical Production Facility

Melbourne (Australia) – 3 April 2020. Telix is pleased to announce it has now completed the acquisition of a licensed radiopharmaceutical production facility in Seneffe, Belgium

Telix Pharmaceuticals Limited is pleased to announce it has now completed the acquisition of a licensed radiopharmaceutical production facility in Seneffe, Belgium from German company Eckert & Ziegler Strahlen und Medizintechnik AG (‘EZAG’).

Telix has previously announced, in October 2019, that it had entered into a conditional agreement with EZAG to acquire the Site. Telix has now completed the acquisition of the Site for a nominal sum (EUR €1) in addition to assuming the future decommissioning liability at the end of the operating lifetime of the Site, currently estimated to be up to €5.2M (A$9.0M).

To read the full media release please click here.